Beckett AH, Rowland M. Urinary excretion kinetics of methylamphetamine in man. Nature.1965;206:1260-1261.
Belpaire FM, Wijnant P, Temmermann A, et al. The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitor. Eur J Clin Pharm. 1998;54(3):261-264.
Coleman MD (2010). Human Drug Metabolism, an Introduction. Wiley-Blackwell.
Gunaraha C. Drug metabolism & pharmacokinetics in drug discovery: a primer for bioanalytical chemists, part 1. Curr Sep. 2000;19(1):19-21.
Handbook of Pharmacogenomics and Stratified Medicine. 2014 Elsevier Inc. Academic Press. ISBN 978-0-12-386882-4 Published 2014
Hesse LM, He P, Krishnaswamy S, et al. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes. Pharmacogenetics. 2004;14(4):225–238.
Kaplan LA, Pesce AJ. Clinical Chemistry Theory, Analysis, Correlation. St Louis, MO: Mosby; 1996: 1021-1022, 1088-1089.
Klaassen CD, Watkins III JB. Casarett & Doull’s Essentials of Toxicology. 3rd ed. New York, NY: McGraw-Hill; 2015.
Milsap RL, Jusko WL. Pharmacokinetics in the infant. Environ Health Perspect. 1994;102(11):107-109.
Nikolas P. Lemos, Eric A. Ingle1. Cannabinoids in Postmortem Toxicology. Journal of Analytical Toxicology, Vol. 35, September 2011
Smith H. Opioid metabolism. Mayo Clin Proc. July 2009;84(7):615–616.
Yamada H, Ishii Y, Oguri K. Metabolism of drugs of abuse: its contribution to the toxicity and the inter-individual differences in drug sensitivity. J of Health Science. 2005;51(1):1-4.